Literature DB >> 12885383

Formulation and characterization of DNA-polyethylenimine-dextran sulfate nanoparticles.

Waree Tiyaboonchai1, James Woiszwillo, C Russell Middaugh.   

Abstract

Polyethylenimine (PEI) is a promising non-viral gene delivery polymer that produces high transfection efficiency both in vitro and in vivo. The use of PEI, however, is hindered by its toxicity, reflecting its polycationic nature. In an attempt to decrease this charge-dependent cytotoxicity, a polyanionic polymer, dextran sulfate (DS), has been incorporated into self-assembling PEI-DNA complexes with zinc as stabilizing agent. Spherical particles with a mean particle size of approximately 200 nm and a polydispersity index of 0.2 were achieved using the following optimal conditions: PEI solutions at pH 8, PEI/DS mass ratios of >or=2, and 25 microM zinc sulfate. Plasmid DNA was completely condensed within the nanoparticles as confirmed by an ethidium bromide accessibility assay. This result correlates well with DNase protection studies which find partial protection of the DNA nanoparticles from degradation by the enzyme. The DNA was incorporated into the PEI-DS particles with a high efficiency (>95%) and maintained a primarily supercoiled B-form as determined by gel electrophoresis and circular dichroism. The cytotoxicity of the DNA nanoparticles appeared to decrease as the amount of DS in the formulation was increased and they produced moderate transfection activities that were only modestly inhibited by the presence of serum.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12885383     DOI: 10.1016/s0928-0987(03)00102-7

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  7 in total

1.  Poly-L-arginine and dextran sulfate-based nanocomplex for epidermal growth factor receptor (EGFR) siRNA delivery: its application for head and neck cancer treatment.

Authors:  Hyun-Jong Cho; Saeho Chong; Suk-Jae Chung; Chang-Koo Shim; Dae-Duk Kim
Journal:  Pharm Res       Date:  2011-12-15       Impact factor: 4.200

Review 2.  Gene therapy in the cornea: 2005--present.

Authors:  Rajiv R Mohan; Jonathan C K Tovey; Ajay Sharma; Ashish Tandon
Journal:  Prog Retin Eye Res       Date:  2011-09-28       Impact factor: 21.198

3.  "Soft" calcium crosslinks enable highly efficient gene transfection using TAT peptide.

Authors:  Abdulgader Baoum; Sheng-Xue Xie; Amir Fakhari; Cory Berkland
Journal:  Pharm Res       Date:  2009-09-30       Impact factor: 4.200

4.  Controlled release of repifermin from polyelectrolyte complexes stimulates endothelial cell proliferation.

Authors:  Min Huang; Cory Berkland
Journal:  J Pharm Sci       Date:  2009-01       Impact factor: 3.534

5.  Cationic surface modification of PLG nanoparticles offers sustained gene delivery to pulmonary epithelial cells.

Authors:  Abdulgader Baoum; Navneet Dhillon; Shilpa Buch; Cory Berkland
Journal:  J Pharm Sci       Date:  2010-05       Impact factor: 3.534

6.  Designing chitosan-dextran sulfate nanoparticles using charge ratios.

Authors:  Yan Chen; Vellore J Mohanraj; Fang Wang; Heather A E Benson
Journal:  AAPS PharmSciTech       Date:  2007-11-30       Impact factor: 3.246

Review 7.  Multifunctional Immunoadjuvants for Use in Minimalist Nucleic Acid Vaccines.

Authors:  Saed Abbasi; Satoshi Uchida
Journal:  Pharmaceutics       Date:  2021-05-01       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.